{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:51:30Z","timestamp":1773521490591,"version":"3.50.1"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1248\/bpb.b20-00392","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T22:06:27Z","timestamp":1604181987000},"page":"1693-1698","source":"Crossref","is-referenced-by-count":18,"title":["Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells &lt;i&gt;via&lt;\/i&gt; Inhibition of Organic Cation Transporter"],"prefix":"10.1248","volume":"43","author":[{"given":"Sirima","family":"Soodvilai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, College of Pharmacy, Rangsit University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paranee","family":"Meetam","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawan","family":"Siangjong","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratchanaporn","family":"Chokchaisiri","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Science, University of Phayao"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichart","family":"Suksamrarn","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunhapas","family":"Soodvilai","sequence":"additional","affiliation":[{"name":"Research Center of Transporter Protein for Medical Innovation and Department of Physiology, Faculty of Science, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kelland L. The resurgence of platinum-based cancer chemotherapy. <i>Nat. Rev. Cancer<\/i>, <b>7<\/b>, 573\u2013584 (2007).","DOI":"10.1038\/nrc2167"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Frezza M, Hindo S, Chen D, Davenport A, Schmitt S, Tomco D, Dou QP. Novel metals and metal complexes as platforms for cancer therapy. <i>Curr. Pharm. Des.<\/i>, <b>16<\/b>, 1813\u20131825 (2010).","DOI":"10.2174\/138161210791209009"},{"key":"3","unstructured":"3) Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. <i>J. Clin. Oncol.<\/i>, <b>21<\/b>, 3194\u20133200 (2003)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Posner MR, Hershock DM, Blajman CR, <i>et al.<\/i> Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. <i>N. Engl. J. Med.<\/i>, <b>357<\/b>, 1705\u20131715 (2007).","DOI":"10.1056\/NEJMoa070956"},{"key":"5","unstructured":"5) Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. <i>J. Clin. Oncol.<\/i>, <b>12<\/b>, 701\u2013706 (1994)."},{"key":"6","unstructured":"6) Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. <i>Kidney Int.<\/i>, <b>73<\/b>, 994\u20131007 (2008)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenst\u00e4dt H, Lanvers-Kaminsky C, am Zehnhoff-Dinnesen A, Schinkel AH, Koepsell H, J\u00fcrgens H, Schlatter E. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. <i>Am. J. Pathol.<\/i>, <b>176<\/b>, 1169\u20131180 (2010).","DOI":"10.2353\/ajpath.2010.090610"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ciarimboli G, Ludwig T, Lang D, Pavenst\u00e4dt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E. Cisplatin nephrotoxicity is critically mediated <i>via<\/i> the human organic cation transporter 2. <i>Am. J. Pathol.<\/i>, <b>167<\/b>, 1477\u20131484 (2005).","DOI":"10.1016\/S0002-9440(10)61234-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. <i>Clin. Pharmacol. Ther.<\/i>, <b>86<\/b>, 396\u2013402 (2009).","DOI":"10.1038\/clpt.2009.139"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. <i>Mol. Cancer Ther.<\/i>, <b>3<\/b>, 1543\u20131549 (2004).","DOI":"10.1158\/1535-7163.1543.3.12"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. <i>Biochem. Pharmacol.<\/i>, <b>74<\/b>, 477\u2013487 (2007).","DOI":"10.1016\/j.bcp.2007.03.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. <i>Toxins <\/i>(Basel), <b>2<\/b>, 2490\u20132518 (2010).","DOI":"10.3390\/toxins2112490"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. Cisplatin-induced cell death is EGFR\/src\/ERK signaling dependent in mouse proximal tubule cells. <i>Am. J. Physiol. Renal Physiol.<\/i>, <b>287<\/b>, F543\u2013F549 (2004).","DOI":"10.1152\/ajprenal.00112.2004"},{"key":"14","unstructured":"14) Santoso JT, Lucci JA 3rd, Coleman RL, Schafer I, Hannigan EV. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. <i>Cancer Chemother. Pharmacol.<\/i>, <b>52<\/b>, 13\u201318 (2003)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tanihara Y, Masuda S, Katsura T, Inui K. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2. <i>Biochem. Pharmacol.<\/i>, <b>78<\/b>, 1263\u20131271 (2009).","DOI":"10.1016\/j.bcp.2009.06.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Cho W, Nam JW, Kang HJ, Windono T, Seo EK, Lee KT. Zedoarondiol isolated from the rhizoma of <i>Curcuma heyneana<\/i> is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines <i>via<\/i> the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages. <i>Int. Immunopharmacol.<\/i>, <b>9<\/b>, 1049\u20131057 (2009).","DOI":"10.1016\/j.intimp.2009.04.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng P, Zhao S, Chen M, Yang G, He G. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2\/M cell cycle arrest and promoting apoptosis. <i>Eur. J. Pharmacol.<\/i>, <b>698<\/b>, 95\u2013102 (2013).","DOI":"10.1016\/j.ejphar.2012.10.013"},{"key":"18","unstructured":"18) Xiao X, Zhao Y, Yuan H, Xia W, Zhao J, Wang X. Study on the effect of rhizoma <i>Curcuma longa<\/i> on gastrin receptor. <i>Zhong Yao Cai<\/i>, <b>25<\/b>, 184\u2013185 (2002)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Li W, Hong B, Li Z, Li Q, Bi K. GC-MS method for determination and pharmacokinetic study of seven volatile constituents in rat plasma after oral administration of the essential oil of Rhizoma Curcumae. <i>J. Pharm. Biomed. Anal.<\/i>, <b>149<\/b>, 577\u2013585 (2018).","DOI":"10.1016\/j.jpba.2017.11.058"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Morikawa T, Matsuda H, Ninomiya K, Yoshikawa M. Medicinal foodstuffs. XXIX. Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by <i>D<\/i>-galactosamine\/lipopolysaccharide or tumor necrosis factor-alpha. <i>Biol. Pharm. Bull.<\/i>, <b>25<\/b>, 627\u2013631 (2002).","DOI":"10.1248\/bpb.25.627"},{"key":"21","unstructured":"21) Chokchaisiri R, Pimkaew P, Piyachaturawat P, Chalermglin R, Suksamrarn A. Cytotoxic sesquiterpenoids and diarylheptanoids from the Rhizomes of <i>Curcuma elata<\/i> Roxb. <i>Rec. Nat. Prod.<\/i>, <b>8<\/b>, 46\u201350 (2014)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Asavapanumas N, Kittayaruksakul S, Meetam P, Muanprasat C, Chatsudthipong V, Soodvilai S. Fenofibrate down-regulates renal OCT2-mediated organic cation transport <i>via<\/i> PPARalpha-independent pathways. <i>Drug Metab. Pharmacokinet.<\/i>, <b>27<\/b>, 513\u2013519 (2012).","DOI":"10.2133\/dmpk.DMPK-11-RG-123"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wongwan T, Kittayaruksakul S, Asavapanumas N, Chatsudthipong V, Soodvilai S. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells. <i>Pflugers Arch.<\/i>, <b>469<\/b>, 1471\u20131481 (2017).","DOI":"10.1007\/s00424-017-2033-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lang K, Wagner C, Haddad G, Burnekova O, Geibel J. Intracellular pH activates 690 membrane-bound Na<sup>+<\/sup>\/H<sup>+<\/sup> exchanger and vacuolar H<sup>+<\/sup>-ATPase in human embryonic kidney (HEK) 691 cells. <i>Cell. Physiol. Biochem.<\/i>, <b>13<\/b>, 257\u2013262 (2003).","DOI":"10.1159\/000074540"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Masuda S, Terada T, Yonezawa A, Tanihara Y, Kishimoto K, Katsura T, Ogawa O, Inui K. Identification and functional characterization of a new human kidney-specific H<sup>+<\/sup>\/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. <i>J. Am. Soc. Nephrol.<\/i>, <b>17<\/b>, 2127\u20132135 (2006).","DOI":"10.1681\/ASN.2006030205"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Pabla N, Murphy RF, Liu K, Dong Z. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. <i>Am. J. Physiol. Renal Physiol.<\/i>, <b>296<\/b>, F505\u2013F511 (2009).","DOI":"10.1152\/ajprenal.90545.2008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wieser M, Stadler G, Jennings P, Streubel B, Pfaller W, Ambros P, Riedl C, Katinger H, Grillari J, Grillari-Voglauer R. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. <i>Am. J. Physiol. Renal Physiol.<\/i>, <b>295<\/b>, F1365\u2013F1375 (2008).","DOI":"10.1152\/ajprenal.90405.2008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Aschauer L, Carta G, Vogelsang N, Schlatter E, Jennings P. Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1. <i>Toxicol. In Vitro<\/i>, <b>30<\/b> (1 Pt A), 95\u2013105 (2015).","DOI":"10.1016\/j.tiv.2014.12.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kaushal GP, Kaushal V, Herzog C, Yang C. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. <i>Autophagy<\/i>, <b>4<\/b>, 710\u2013712 (2008).","DOI":"10.4161\/auto.6309"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ivy KD, Kaplan JH. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum\u2013drug entry into human cells. <i>Mol. Pharmacol.<\/i>, <b>83<\/b>, 1237\u20131246 (2013).","DOI":"10.1124\/mol.113.085068"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/11\/43_b20-00392\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T01:30:10Z","timestamp":1669426210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/11\/43_b20-00392\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00392","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}